Difficulties in managing patients with hepatolenticular degeneration

Cover Page

Cite item

Full Text


In this paper, we present some typical problems of managing patients with hepatolenticular degeneration (HLD), a severe hereditary disorder of cupper metabolism requiring permanent cupper-eliminating therapy. Special attention should be paid the following questions: choice of combined treatment with D-penicillamine (D-PAM) and zinc vs. monotherapy with either of these medications; the possibility of temporary worsening of neurologic symptoms induced by massive increase in free copper level in the blood following therapy with D-PAM; the need for special psychological support of patients and their relatives; strict adherence to a regimen prohibiting physical exercises and the need for following a special diet. Two clinical cases have been described: a fatal case of many-year compensated HLD after a physical load during a travel to the seaside, and a case of an infected foot wound in a HLD patient with the development of septicopyaemia (lower leg phlegmon and osteomyelitis of the lumbar vertebrae) following a physical activity and violation of the dietary pattern. 

About the authors

Tatyana N. Proskokova

Far-Eastern State Medical University

Author for correspondence.
Email: proskokova2011@yandex.ru
Russian Federation, Khabarovsk

Nadezhda V. Vyalova

Far-Eastern State Medical University

Email: proskokova2011@yandex.ru
Russian Federation, Khabarovsk

Natal'ya B. Serdyuk

Far Eastern State Medical University, Ministry of Health of the Russian Federation

Email: proskokova2011@yandex.ru
Russian Federation, Khabarovsk

Aleksandr M. Khelimsky

Far-Eastern State Medical University

Email: proskokova2011@yandex.ru
Russian Federation, Khabarovsk


  1. Ekstrapiramidnye rasstroystva: Rukovodstvo po diagnostike i lecheniyu. [Extrapyramidal disorders. Guideline on diagnosis and treatment] Eds: V.N. Shtok, I.A. Ivanova-Smolenskaya, O.S. Levin. Moscow: MEDpress-inform, 2002: 495-502. (In Russ.)
  2. Rodrigues-Castro K.I., Hevia-Urputia F.J.,Sturniolo G.C. Wilson's disease: a review of what we have learned. World J. Hepatol. 2015; 87: 2859-2870. PMID: 26692151 doi: 10.4254/wjh.v7.i29.2859
  3. Khandpur S., Jain N., Singla S. et al. D-penicillamine induced degenerative dermopathy. Indian J. Dermatol. 2015; 60: 406-409. PMID: 26288416 doi: 10.4103/0019-5154.160498
  4. Chen J.C., Chuang C.H., Wang J.D., Wang C.W. Combination therapy using chelating agent and zinc for Wilson for Wilson disease. J. Med. Biol. Eng. 2015; 35: 697-708. PMID: 26692828 doi: 10.1007/s40846-015-0087-7
  5. Santiago R., Gottrand F., Debray D. et al. Zinc therapy for Wilson disease in children in French pediatric centers. J. Pediatr. Gastroenterol. Nutr. 2015; 61: 613-618. PMID: 26230903 doi: 10.1097/MPG.0000000000000926
  6. Aggarwal A. The pragmatic treatment of Wilson's disease. Mov. Disord. Clin. Practice. 2014: 10 p. DOI: 10. 1002/ mdc3.12003
  7. Bandmann O., Weiss K.H., Kaler S.G. Wilson's disease and other neurological copper disorders. Lancet. Neurol. 2015; 14: 103-113. PMID: 25496901 doi: 10.1016/S1474-4422(14)70190-5
  8. Rosencrantz R., Schilsky M. Wilson disease: pathogenesis and clinical consideration in diagnosis and treatment. Semin. Liver. Dis. 2011; 31: 245-259. PMID: 21901655 doi: 10.1055/s-0031-1286056
  9. Donaldson I., Marsden C.D., Schneider S.A., Bhatia K.P. Marsden’s book of movement disorders. Oxford, 2012: 493-519.
  10. Ranjan A., Kalita J., Kumar V., Misra U.K. MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine. Neurotoxicology. 2015; 49: 45-49. PMID: 26004675 doi: 10.1016/j.neuro.2015.05.004
  11. Litwin T., Dziezic K., karlinski M., Chabik G. et al. Early neurological worsening in patients with Wilson's disease. J. Neurol. Sci. 2015; 355: 162-167. PMID: 26071888 doi: 10.1016/j.jns.2015.06.010
  12. Rau A. R., Usha M., Mallya P., Rau A. T. K. Cytopenia and bone marrow dysplasia in a case of Wilson's disease. Indian J. Hematol. Blood Transfus. 2014; 30 (Suppl. 1): 433-436. PMID: 25332639 doi: 10.1007/s12288-014-0456-3

Supplementary files

Supplementary Files

Copyright (c) 2018 Proskokova T.N., Vyalova N.V., Serdyuk N.B., Khelimsky A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies